AstraZeneca, Toshiba, and happy staff

Today Ian's discussing Covid vaccine maker AstraZeneca's decision to move away from its at-cost model, and will now aim to make a 'modest profit' from the jabs.

He's also considering the break-up of Toshiba, and is joined by the maker of an app which aims to make employees happier.